首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1461422

人工心臟瓣膜市場：依地點類型、依瓣膜類型、依最終用戶、按地區

Prosthetic Heart Valve Market, By Position Type, By Valve Type, By End User,, By Geography .

出版日期: 2024年03月08日 | 出版商:

Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

人造心臟瓣膜市場預計2024年為132.1億美元，預計到2031年將達到282.9億美元，2024年至2031年的年複合成長率（CAGR）為11.5%。

報告範圍		報告詳情
基準年	2023年	2023/2024年市場規模	132.1億美元
實際資料	2019-2023	預測期	2024-2031
2023/2024-2030/2031預測期年複合成長率	11.50%	2030/2031 年預測值	282.9億美元

2024 年按地區分類的人工心臟瓣膜市場佔有率(%)

由於瓣膜性心臟病的盛行率不斷上升以及瓣膜置換手術的數量不斷增加，人造心臟瓣膜市場在過去幾年中經歷了穩定成長。人工心臟瓣膜有助於替換無法正常運作的受損心臟瓣膜。老化、吸菸、肥胖和糖尿病等危險因子顯著增加了患有二尖瓣瓣膜閉鎖不全、主動脈瓣膜閉鎖不全和狹窄等心臟瓣膜疾病的患者數量。此外，從機械瓣膜到生物瓣膜的瓣膜設計技術進步以及醫療保健成本的增加也促進了全球人造心臟瓣膜市場的成長。然而，高昂的治療費用仍然是阻礙更廣泛普及的主要問題。

市場動態：

主要國家老年人口的增加以及瓣膜性心臟病負擔的增加是人造心臟瓣膜市場的主要成長動力。據估計，光在美國超過 1,600 萬人患有瓣膜性心臟病。肥胖和糖尿病是瓣膜性心臟病發展的主要危險因素，其盛行率的增加正在補充市場的成長。此外，採用技術先進的微創經導管心臟瓣膜取代傳統的心臟直視手術逐漸普及，從而增加了市場收益。然而，與瓣膜置換手術相關的高昂費用限制了其普及，特別是在發展中地區。新產品核可的嚴格監管指南也對市場產生負面影響。然而，持續研發以開發價格實惠的設備和增強技術為人工心臟瓣膜製造商在未來幾年帶來了重大機會。

本研究的主要特點

本報告詳細分析了全球人工心臟瓣膜市場，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它還闡明了不同細分市場的潛在收益成長機會，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球人工心臟瓣膜市場的主要企業。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球人工心臟瓣膜市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球人工心臟瓣膜市場的各種策略矩陣來促進決策。

市場動態
- 促進因素
- 抑制因素
- 機會
影響分析
PEST分析
波特分析
技術進步
合併、收購和合作場景
最近的產品核可
確定每個地區的主要參與企業
監管場景
價格分析
COVID-19 影響分析
流行病學
各國醫療費用支出
贖回場景
經銷商狀況
品牌映射
比賽簡介
企業定位分析
熱圖分析

第4章全球人工心臟瓣膜市場，依地點類型，2019-2031

介紹
主動脈瓣
二尖瓣
其他

第5章2019-2031年全球人工心臟瓣膜市場（依瓣膜類型）

介紹
機械閥
組織瓣膜
經導管瓣膜

第6章全球人工心臟瓣膜市場，依最終使用者分類，2019-2031 年

介紹
醫院
門診手術中心
導管檢測室
其他

第7章2019-2031年全球人工心臟瓣膜市場（按地區）

介紹
北美洲
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
東南亞國協
其他亞太地區
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
中東
波灣合作理事會
以色列
其他中東地區
非洲
南非
北非
中部非洲

第8章競爭格局

第9章公司簡介-全球人工心臟瓣膜市場

Edwards Lifesciences Corporation
最新動態/更新
Medtronic plc.
Boston Scientific Corporation
Abbott Laboratories
LivaNova PLC
CryoLife Inc.
Braile Biomedica
Colibri Heart Valve LLC
JenaValve Technology Inc.
TTK Healthcare Limited
Lepu Medical Technology Co. Ltd
Foldax, Inc.
Symetis SA
On-X Life Technologies
Braile Biomedica

第10章盛衰

繁榮與衰落
綜合機會圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI69

The prosthetic heart valve market is estimated to be valued at USD 13.21 Bn in 2024 and is expected to reach USD 28.29 Bn by 2031, growing at a compound annual growth rate (CAGR) of 11.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 13.21 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	11.50%	2030/2031 Value Projection:	US$ 28.29 Bn

Prosthetic Heart Valve Market Share (%), By Region, 2024

The prosthetic heart valve market has been witnessing steady growth over the past few years owing to the increasing prevalence of heart valve diseases and rising number of valve replacement surgeries. Prosthetic heart valves help in replacing damaged heart valves that do not function properly. There has been a substantial increase in the patient pool suffering from heart valve conditions such as mitral and aortic regurgitation or stenosis due to aging population and risk factors like smoking, obesity, and diabetes. Moreover, technological advancements in valve design from mechanical valves to bioprosthetic valves and rising healthcare expenditure have been contributing towards the growth of the prosthetic heart valve market globally. However, high cost of treatment remains a key concern inhibiting wider adoption.

Market Dynamics:

Rising geriatric population base along with increasing burden of heart valve diseases across major countries act as the major growth drivers for the prosthetic heart valve market. As per estimates, over 16 million people suffer from valve diseases in the U.S. alone. The growing prevalence of obesity and diabetes which are major risk factors for developing valve defects supplement the market growth. Furthermore, introduction of technologically advanced, minimally invasive transcatheter heart valves as an alternative to conventional open-heart surgeries is gradually gaining adoption, bolstering the market revenues. However, prohibitively high costs associated with valve replacement surgeries limits widespread adoption, especially in developing regions. Stringent regulatory guidelines for new product approvals also impacts the market adversely. But ongoing R&D for developing affordable devices and enhanced technologies presents significant opportunities for prosthetic heart valve manufacturers over coming years.

Key Features of the Study:

This report provides an in-depth analysis of the global prosthetic heart valve market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prosthetic heart valve market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife Inc., Braile Biomedica, Colibri Heart Valve LLC, JenaValve Technology , TTK Healthcare Limited , Lepu Medical Technology Co. Ltd , Foldax, Inc. , Symetis SA , On-X Life Technologies, and Braile Biomedica
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global prosthetic heart valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prosthetic heart valve market

Market Segmentation

Valve Type:
- Mechanical Valves
- Tissue Valves
- Transcatheter Valves
Position Type:
- Aortic Valve
- Mitral Valve
- Others
End User:
- Hospitals
- Ambulatory Surgical Centers
- Catheterization Laboratory
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Edwards Lifesciences Corporation
- Medtronic plc.
- Boston Scientific Corporation
- Abbott Laboratories
- LivaNova PLC
- CryoLife Inc.
- Braile Biomedica
- Colibri Heart Valve LLC
- JenaValve Technology Inc.
- TTK Healthcare Limited
- Lepu Medical Technology Co. Ltd
- Foldax, Inc.
- Symetis SA
- On-X Life Technologies
- Braile Biomedica

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Position Type
- Market Snapshot, By Valve Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals
Identification of Key Players in Each Region
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Epidemiology
Healthcare Spending, by Country
Reimbursement Scenario
Distributors Landscape
Brand Mapping
Competitive Snapshot
Company Positioning Analysis
Heat Map Analysis

4. Global Prosthetic Heart Valve Market, By Position Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Aortic Valve, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Mitral Valve, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Prosthetic Heart Valve Market, By Valve Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Mechanical Valves, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Tissue Valves, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Transcatheter Valves, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Prosthetic Heart Valve Market, By End User, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Hospitals, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Ambulatory Surgical Centers, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Catheterization Laboratory, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Prosthetic Heart Valve Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2024 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

8. Competitive Landscape

Competitive Snapshot
What Market Participants are Saying?
Competitive Dashboard
Company Market Share Analysis, 2024 - Global

9. Company Profiles - Global Prosthetic Heart Valve Market

Edwards Lifesciences Corporation*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Medtronic plc.
Boston Scientific Corporation
Abbott Laboratories
LivaNova PLC
CryoLife Inc.
Braile Biomedica
Colibri Heart Valve LLC
JenaValve Technology Inc.
TTK Healthcare Limited
Lepu Medical Technology Co. Ltd
Foldax, Inc.
Symetis SA
On-X Life Technologies
Braile Biomedica